Biocartis

In Brief This Week: Prenetics, Biocartis, Bruker

News items for the week of Nov. 20, 2023

New Products Posted to GenomeWeb: Medicover Genetics, Biocartis, Curio Bioscience, More

New products and services posted to GenomeWeb for the week of Oct. 16, 2023

In Brief This Week: 10x Genomics, Congenica, Epigenomics, Myriad Genetics, Biocartis, More

News items for the week of Oct. 9, 2023

Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent

The company said that its secured creditors have recapitalized its operating subsidiaries and restructured its balance sheet to reduce its debt burden by €132 million.

People in the News at NanoString, Invitae, Telesis Bio, Biocartis, Delve Bio, Co-Diagnostics

Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Aug. 28, 2023.

Aug 10, 2023

Biocartis, Eli Lilly Partner for Spanish NSCLC Biomarker Study

Jul 21, 2023

People in the News at 10x Genomics, OraSure, Biocartis, Lex Diagnostics, Opentrons, More

Jun 20, 2023

Biocartis Laying Off 140 Employees as Part of Reorganization Plan

Jun 9, 2023

People in the News at Biocartis, Angle, Nucleix, Almaden Genomics, SomaLogic, More

Apr 21, 2023

In Brief This Week: UC Berkeley, Biocept, Biocartis, Angle, Twist Bioscience, More

Apr 14, 2023

People in the News at Adaptive Biotechnologies, Biocartis, Sherlock Biosciences, Epigenomics, More

Apr 4, 2023

Biocartis, Apis Assay Technologies to Develop Breast Cancer Subtyping Test

Mar 10, 2023

BioMérieux, Biocartis, Beckman Coulter Gain FDA 510(k) Clearances in February

Mar 2, 2023

Biocartis Nabs FDA 510(k) Clearance for Lynch Syndrome Screening Assay

Feb 24, 2023

People in the News at Natera, Delfi Diagnostics, Biocartis, Ansa Bio, Lex Diagnostics, More

Feb 24, 2023

In Brief This Week: Personalis, Biocartis, Opko Health, Berkeley Lights, More

Feb 10, 2023

New Products Posted to GenomeWeb: Thermo Fisher, Exact Sciences, Biocartis, BioSkryb, More

Jan 20, 2023

In Brief This Week: Burning Rock Biotech, Biocartis, NYGC, Eagle Genomics, Theradiag, OpGen, More

Oct 21, 2022

Biocartis Reports 14 Percent Increase in Q3 Product Revenue

Oct 10, 2022

Ophiomics Liver Cancer Assay Gets CE-IVD Mark

Sep 1, 2022

SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay

Sep 1, 2022

Biocartis Posts 21 Percent Jump in H1 Revenues

Aug 26, 2022

In Brief This Week: Genetron, MDxHealth, Biocept, Beckman Coulter, Biocartis, Satio, More

Jun 22, 2022